Companies / Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

Nasdaq: CRNXCIK 1658247SAN DIEGO, CAcrinetics.com ↗

Financials · FY2025

Revenue$7.70M
Net income$-465.32M
Total debt—
Cash$55.50M
Diluted EPS$-4.95
Shares outstanding106.1M

Ownership

106.1M shares outstanding · as of Jul 22, 2026
0.48%Insiders
Ownership
Insiders0.48%513,597
10%+ / strategic1.36%1,439,891
Institutions95.82%101,630,306
Public float2.34%2,481,435

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 10

View all →
Insider% of sharesShares
Struthers Richard ScottCEOFormerPresident & CEO · Director
0.38%404,778
Betz Stephen F.Chief Scientific Officer
0.13%137,101
Wierenga WendellDirector
0.12%122,071
Knight Jeff E.Chief Operating Officer
0.11%112,018
Schilke TobinChief Financial Officer
0.07%78,121
Kalofonos IsabelFormerChief Commercial Officer
0.03%34,834
Fust Matthew KDirector
0.03%28,761
Bedrosian Camille LDirector
0.02%22,225
Vivaldi Coelho RogerioFormerDirector
0.02%16,300
Okey StephanieDirector
0.01%13,300

Institutional holders 250

View all →
HolderValue% of shares
Fmr LLC$665.38M13.48%
Vanguard Group Inc$425.26M8.61%
Wellington Management Group LLP$374.16M7.58%
BlackRock, Inc.$365.18M9.20%
Farallon Capital Management LLC$322.74M6.54%
Driehaus Capital Management LLC$297.35M6.02%
EcoR1 Capital, LLC$199.61M4.04%
Janus Henderson Group PLC$164.23M4.26%
Point72 Asset Management, L.P.$108.79M2.20%
Paradigm BioCapital Advisors LP$102.91M2.08%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 16, 2026Struthers Richard Scott
CEO
SellCommon Stock$489.7K-13K
-3.09%
413,563
0.39% of shares
medium
Mar 16, 2026Struthers Richard Scott
CEO
SellCommon Stock$331.8K-9K
-2.12%
404,778
0.38% of shares
medium
Mar 3, 2026Schilke Tobin
Executive
SellCommon Stock$266.3K-7K
-7.91%
78,121
0.07% of shares
medium
Mar 16, 2026Betz Stephen F.
Executive
SellCommon Stock$236.4K-6K
-4.31%
141,342
0.13% of shares
medium
Mar 16, 2026Knight Jeff E.
Executive
SellCommon Stock$220.8K-6K
-4.88%
115,979
0.11% of shares
medium
Mar 12, 2026Vivaldi Coelho Rogerio
Director
SellCommon Stock$161.5K-4K
-21.02%
16,823
0.02% of shares
medium
Mar 16, 2026Betz Stephen F.
Executive
SellCommon Stock$160.2K-4K
-3.00%
137,101
0.13% of shares
medium
Mar 16, 2026Knight Jeff E.
Executive
SellCommon Stock$149.6K-4K
-3.42%
112,018
0.11% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Fmr LLCPassive13G/A—1,439,891—
Vanguard Group IncPassive13G/A—0—
Farallon Capital Partners, L.P.Passive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
CRNX——22663K107—